Chinese Covid-19 vaccines: Sinopharm is safe for children as young as 3, says study
Auteur : Simone McCarthy, journaliste du journal South China Morning Post à Hong Kong
Production : South China Morning Post, quotidien de langue anglaise publié à Hong Kong depuis 1903. Sa diffusion s’élève à 104 000 exemplaires. Il est publié par le groupe SCMP, propriété de du groupe Alibaba depuis 2015.
Diffusion : site du journal South China Morning Post
Date et Heure : 17 septembre 2021, 18:00
– The research also found that the vaccine induced a similar immune response to that found among adults
– The data was released as a fresh cluster of cases in primary school children has intensified the debate about vaccinating under-12s
Source : Simone McCarthy, “Chinese Covid-19 vaccines: Sinopharm is safe for children as young as 3, says study”, South China Morning Post, 17/09/2021. URL : https://www.scmp.com/news/china/science/article/3149159/chinese-covid-19-vaccines-sinopharm-safe-children-young-3-says (consulté le 20/09/2021).
L’article de référence :
ShengLi Xia, YunTao Zhang, YanXia Wang [et al.], “Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial”, The Lancet, 15/09/2021. DOI : https://doi.org/10.1016/S1473-3099(21)00462-X (consulté le 20/09/2021).
Photo “à la une” : China is now vaccinating children aged 12 and older. © Xinhua
OpenEdition vous propose de citer ce billet de la manière suivante :
Admin IAO (17 septembre 2021). Chinese Covid-19 vaccines: Sinopharm is safe for children as young as 3, says study. Asie Orientale et Coronavirus. Consulté le 25 mars 2025 à l’adresse https://doi.org/10.58079/n89y